Use of cardiotrophin to modulate stem cell proliferation

Details for Australian Patent Application No. 2004249340 (hide)

Owner Ottawa Hospital Research Institute

Inventors Megeney, Lynn

Agent Allens Arthur Robinson

Pub. Number AU-B-2004249340

PCT Pub. Number WO2004/113380

Priority 60/482,001 25.06.03 US

Filing date 25 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 21 April 2011

International Classifications

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C12N 5/077 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/113380 Priority application(s): WO2004/113380

21 April 2011 Application Accepted

  Published as AU-B-2004249340

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249343-Glycosidase inhibitors and methods of synthesizing same

2004249339-Device and method for comminuting materials